Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.84 |
| ▸ | MEN1 | O00255 | 3/20 | 0.84 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.84 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.84 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.84 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.84 |
| ▸ | GLA | P06280 | 1/20 | 0.84 |
| ▸ | HPGD | P15428 | 1/20 | 0.84 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.84 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | ME2 | P23368 | 1/20 | 0.45 |
| ▸ | ME1 | P48163 | 1/20 | 0.45 |
| ▸ | ME3 | Q16798 | 1/20 | 0.45 |
| ▸ | CDC25B | P30305 | 3/20 | 0.45 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.44 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31125071 | 0.92 | KDM4E (0.69) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| Anthracene-9-Carboxylic Acid SCHEMBL122832 | 0.92 | MEN1 (1.00) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| Anthracene-9-Carboxylic Acid SCHEMBL29352186 | 0.92 | MEN1 (1.00) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| Anthracene-9-Carboxylic Acid SCHEMBL28099540 | 0.90 | MEN1 (0.95) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| Anthracene-9-Carboxylic Acid SCHEMBL27733356 | 0.90 | MEN1 (0.95) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| Anthracene-9-Carboxylic Acid SCHEMBL28121546 | 0.90 | MEN1 (0.95) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| Anthracene-9-Carboxylic Acid SCHEMBL7054301 | 0.90 | MEN1 (0.95) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| Anthracene-9-Carboxylic Acid SCHEMBL11788252 | 0.90 | MEN1 (0.95) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| Anthracene-9-Carboxylic Acid SCHEMBL28243282 | 0.88 | MEN1 (0.91) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 | |
| SCHEMBL4896927 | 0.84 | ALDH1A1 (0.59) | ALDH1A1MEN1KMT2AKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111303860-B | Long-afterglow luminescent material based on quantum dot sensitization and application thereof | 复旦大学 | 2021-05-14 | — | — | CN | claimed |
| CN-111303860-A | Long-afterglow luminescent material based on quantum dot sensitization and application thereof | 复旦大学 | 2020-06-19 | — | — | CN | claimed |
| CN-109862890-A | Purifying CENICRIVIROC and the purifying intermediate for being used to prepare CENICRIVIROC | 妥必徕疗治公司 | 2019-06-07 | — | — | CN | claimed |
| CN-113412261-A | Benzimidazole compounds, preparation method and use thereof | 四川科伦博泰生物医药股份有限公司 | 2021-09-17 | — | — | CN | disclosed |
| CN-111303860-B | Long-afterglow luminescent material based on quantum dot sensitization and application thereof | 复旦大学 | 2021-05-14 | — | — | CN | disclosed |
| CN-111303860-A | Long-afterglow luminescent material based on quantum dot sensitization and application thereof | 复旦大学 | 2020-06-19 | — | — | CN | disclosed |
| US-10351580-B2 | Acene-based transmitter molecules for photon upconversion | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-07-16 | — | — | US | disclosed |
| EP-2491915-B1 | EASILY REMOVABLE CURABLE COMPOSITION FOR DENTAL USE | SUN MEDICAL CO LTD (JP) | 2019-07-03 | — | — | EP | disclosed |
| CN-109862890-A | Purifying CENICRIVIROC and the purifying intermediate for being used to prepare CENICRIVIROC | 妥必徕疗治公司 | 2019-06-07 | — | — | CN | disclosed |
| EP-2491915-A1 | EASILY REMOVABLE CURABLE COMPOSITION FOR DENTAL USE | SUN MEDICAL CO., LTD. (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-20120213832-A1 | REMOVABLE DENTAL CURABLE COMPOSITION | SUN MEDICAL CO., LTD. (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20080044149-A1 | Polymerizable Composition | TOYO INK MFG. CO., LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
| EP-1816152-A1 | POLYMERIZABLE COMPOSITION | TOYO INK MFG. CO., LTD. (JP) | 2007-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351580-B2 | Acene-based transmitter molecules for photon upconversion | ACE, ACE2, AGTR1 | ALDH1A1 93/4885MEN1 1290/4885KMT2A 4292/4885 |
| US-20120213832-A1 | REMOVABLE DENTAL CURABLE COMPOSITION | SMARCA5, SMARCA1, SMARCA2 | ALDH1A1 1369/4885MEN1 2816/4885KMT2A 273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.